This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Serotonergic psychedelic: Difference between revisions
>Unity Removed approvalheader. |
>Unity m Reorder |
||
| Line 191: | Line 191: | ||
==Literature== | ==Literature== | ||
* Nichols, D. E. (2016). '''''Psychedelics.''''' ''Pharmacological Reviews'', 68(2), 264-355. https://doi.org/10.1124/pr.115.011478 | * Nichols, D. E. (2016). '''''Psychedelics.''''' ''Pharmacological Reviews'', 68(2), 264-355. https://doi.org/10.1124/pr.115.011478 | ||
* Geyer, M. A., Nichols, D. E., & Vollenweider, F. X. (2009). '''''Serotonin-Related Psychedelic Drugs.''''' ''Encyclopedia of Neuroscience''. https://doi.org/10.1016/b978-008045046-9.01160-8 | * Geyer, M. A., Nichols, D. E., & Vollenweider, F. X. (2009). '''''Serotonin-Related Psychedelic Drugs.''''' ''Encyclopedia of Neuroscience''. https://doi.org/10.1016/b978-008045046-9.01160-8 | ||
* Nichols, C. D., & Sanders-Bush, E. (2001). '''''Serotonin Receptor Signaling and Hallucinogenic Drug Action'''''. ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf | * Nichols, C. D., & Sanders-Bush, E. (2001). '''''Serotonin Receptor Signaling and Hallucinogenic Drug Action'''''. ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf | ||
| Line 200: | Line 199: | ||
* Nichols, D. E. (2004). '''''Hallucinogens'''''. ''Pharmacology & Therapeutics'', 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002 | * Nichols, D. E. (2004). '''''Hallucinogens'''''. ''Pharmacology & Therapeutics'', 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002 | ||
* Vollenweider, F. X., & Kometer, M. (2010). '''''The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders'''''. ''Nature Publishing Group'', 11(9), 642–651. https://doi.org/10.1038/nrn2884 | * Vollenweider, F. X., & Kometer, M. (2010). '''''The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders'''''. ''Nature Publishing Group'', 11(9), 642–651. https://doi.org/10.1038/nrn2884 | ||
* Johansen, P. Ø., & Krebs, T. S. (2015). '''''Psychedelics not linked to mental health problems or suicidal behavior: A population study'''''. ''Journal of Psychopharmacology'', 29(3), 270-279. https://doi.org/10.1177/0269881114568039 | |||
===Specific Examples=== | ===Specific Examples=== | ||